Clinical trials: Epidemiology
Pyruvate Kinase Deficiency
Pyruvate Kinase Deficiency Epidemiological Study (PIECE)
Pyruvate kinase deficiency (PKD) is the most common red cell glycolytic enzyme defect causing hereditary non-spherocytic hemolytic anemia, caused by mutations in the PKLR gene.
- Trial name
- PIECE (NCT03866590)
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- CENTOGENE GmbH Rostock
Coronavirus
At Home Monitoring for Patients With Covid19
The vast majority of individuals with Covid19 have mild illness that can be managed in the outpatient setting. A small but significant number of these people will deteriorate and require hospitalization.
- Trial name
- NCT04453774
- Testing
- Covidfree@home
- Where
- 2 sites in Canada
- Volunteers
- 432 people
- Sponsor
- University Health Network, Toronto
Anaemia
Triple Outcome Evaluation of Red Teff Intervention for Infant Anemia, Environmental Health, and Economic Feasibility in Ethiopia: A Self-controlled Pre-post Study
Background. Childhood anemia affects more than 40% of under-five children in Ethiopia, where iron supplementation has achieved limited success and locally grounded, sustainable strategies are needed.
- Trial name
- NCT07912697
- Testing
- Red teff (Eragrostis teff) porridge
- Where
- Ethiopia
- Volunteers
- 32 people
- Sponsor
- Debre Markos University